Naturally Splendid Announces Re-assignment of Director to Advisory Board

- February 26th, 2016

Naturally Splendid (TSXV:NSP) announced that Mr. Charlie Brink has stepped down from the Board of Directors and has been assigned to the Naturally Splendid Advisory Board where he will focus on advancing a wide spectrum of technologies focused on commercializing cannabinoid opportunities.

Naturally Splendid (TSXV:NSP) announced that Mr. Charlie Brink has stepped down from the Board of Directors and has been assigned to the Naturally Splendid Advisory Board where he will focus on advancing a wide spectrum of technologies focused on commercializing cannabinoid opportunities.
As quoted in the press release:

This assignment to the Advisory Board, allows Mr. Brink to focus on advancing cannabinoid technologies that his company, Full Spectrum Laboratories Limited, has been advancing over the past several years.
As a member of the Naturally Splendid Advisory Board, Mr. Brink will continue to provide Naturally Splendid with strategic advice in connection with HempOmega™ and the cannabinoid technologies licensed under the restated and amended license agreement (the “Restated and Amended License Agreement”) between Naturally Splendid and Full Spectrum Laboratories Limited (“FSL”), as announced in the September 23, 2015 news release.

Naturally Splendid CEO, Craig Goodwin, stated:

FSL has made significant advancements in the area of advanced cannabinoid technologies that requires much more of Mr. Brink’s attention. The benefit to Naturally Splendid is that we have certain rights to the advancements made on the technologies that FSL are funding. In short, FSL has taken the initiative to advance these technologies while assuming the financial responsibilities associated with the research and development and Naturally Splendid will receive certain benefits of the improvements made to these technologies.

Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply